Literature DB >> 24138454

The clinical value of cardiac sympathetic imaging in heart failure.

Thomas Emil Christensen1, Andreas Kjaer, Philip Hasbak.   

Abstract

The autonomic nervous system plays an important role in the pathology of heart failure. The single-photon emission computed tomography tracer iodine-123-metaiodobenzylguanidine ((123) I-MIBG) can be used to investigate the activity of the predominant neurotransmitter of the sympathetic nervous system, norepinephrine. Also, positron emission tomography tracers are being developed for the same purpose. With (123) I-MIBG as a starting point, this brief review introduces the modalities used for cardiac sympathetic imaging.
© 2013 Scandinavian Society of Clinical Physiology and Nuclear Medicine. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  cardiac positron emission tomography; cardiac single-photon emission computed tomography; heart failure; iodine-123-metaiodobenzylguanidine; norepinephrine; prognostic marker; sympathetic nervous system

Mesh:

Substances:

Year:  2013        PMID: 24138454     DOI: 10.1111/cpf.12091

Source DB:  PubMed          Journal:  Clin Physiol Funct Imaging        ISSN: 1475-0961            Impact factor:   2.273


  3 in total

Review 1.  The Type 2 Diabetic Heart: Its Role in Exercise Intolerance and the Challenge to Find Effective Exercise Interventions.

Authors:  J Chris Baldi; Genevieve A Wilson; Luke C Wilson; Gerard T Wilkins; Regis R Lamberts
Journal:  Sports Med       Date:  2016-11       Impact factor: 11.136

Review 2.  PET imaging of the autonomic myocardial function: methods and interpretation.

Authors:  Walter Noordzij; Riemer H J A Slart
Journal:  Clin Transl Imaging       Date:  2015-09-10

Review 3.  The prognostic value of 123I-mIBG SPECT cardiac imaging in heart failure patients: a systematic review.

Authors:  Mariano Pontico; Gabriele Brunotti; Miriam Conte; Ferdinando Corica; Laura Cosma; Cristina De Angelis; Maria Silvia De Feo; Julia Lazri; Antonio Matto; Melissa Montebello; Arianna Di Rocco; Viviana Frantellizzi; Alessio Farcomeni; Giuseppe De Vincentis
Journal:  J Nucl Cardiol       Date:  2021-01-13       Impact factor: 3.872

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.